# Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin.

> **NCT05760456** · PHASE3 · UNKNOWN · sponsor: **Centre of Clinical Pharmacology, Hanoi Medical University** · enrollment: 140 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** DIDALA hard capsules
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT05760456
- **Lead sponsor:** Centre of Clinical Pharmacology, Hanoi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-15
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-08-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05760456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05760456, "Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05760456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*